Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (30 ops.)
Latest filing published 18 Mar 2026 for Ionis Pharmaceuticals INC, €3.2M. Read the official filing
Filing timeline
BuySaleElizabeth L. Hougen
Insider track record
Disclosed buys
0
Disclosed sells
30
Signal history
Elizabeth L. Hougen: trading record in brief
Elizabeth L. Hougen is a declared insider of Ionis Pharmaceuticals Inc (finance chief), with filings sourced from SEC (Form 4). The record holds 93 filings, for trades running from 1 January 2016 to 16 March 2026.
Every open-market trade on record is a sale: 30 sales worth €4.6M. Outside the open market, there are 8 share grants and 41 option exercises.
On 18 March 2026 came the latest disclosure, an option exercise for €3.2M in Ionis Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Elizabeth L. Hougen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations93 total
60,299 shares@ US$60.890.038% mcap42.6% of flowCommon StockSEC:0000874015-26-000146:0
13,562 shares0Common StockSEC:0000874015-26-000098:0
28,729 shares0Common StockSEC:0000874015-26-000065:0
49,800 shares@ US$53.7730.2% of flowCommon StockSEC:0000874015-25-000238:0
4,138 shares0Common StockSEC:0000874015-25-000077:0
23,887 shares0Common StockSEC:0000874015-25-000060:0
2,162 shares@ US$49.53991.3% of flowCommon StockSEC:0000874015-24-000199:0
4,140 shares0Common StockSEC:0000874015-24-000106:0
22,487 shares0Common StockSEC:0000874015-24-000075:0
45,225 shares@ US$47.3425.5% of flowCommon StockSEC:0000874015-24-000005:0
163 shares@ US$30.5150.1% of flowCommon StockSEC:0000874015-23-000113:0
4,140 shares0Common StockSEC:0000874015-23-000092:0
23,154 shares0Common StockSEC:0000874015-23-000065:0
202 shares@ US$28.9680.1% of flowCommon StockSEC:0000874015-22-000154:0
384 shares@ US$28.3730.1% of flowCommon StockSEC:0000874015-22-000088:0
22,050 shares0Common StockSEC:0000874015-22-000054:0
166 shares@ US$33.7960.1% of flowCommon StockSEC:0000874015-21-000154:0
21,680 shares@ US$39.876.4% of flowCommon StockSEC:0000874015-20-000160:0
21,680 shares@ US$50.058.1% of flowCommon StockSEC:0000874015-20-000160:1
13,125 shares@ US$39.873.9% of flowCommon StockSEC:0000874015-20-000150:0
13,125 shares@ US$50.114.9% of flowCommon StockSEC:0000874015-20-000150:1
5,875 shares@ US$39.871.8% of flowCommon StockSEC:0000874015-20-000150:2
5,875 shares@ US$50.112.2% of flowCommon StockSEC:0000874015-20-000150:3
4,320 shares@ US$39.871.3% of flowCommon StockSEC:0000874015-20-000150:4
4,320 shares@ US$50.831.6% of flowCommon StockSEC:0000874015-20-000150:5
25 of 93 declarations
